Yüklüyor......
Adherence and Out-of-Pocket Cost Among Medicare Beneficiaries Prescribed Oral Targeted Therapies for Advanced Prostate Cancer
BACKGROUND: Abiraterone and enzalutamide are high-cost oral therapies increasingly used to treat patients with advanced prostate cancer, carrying the potential for significant financial consequences to patients. We investigated coping and material measures of financial hardship of these therapies am...
Kaydedildi:
| Yayımlandı: | Cancer |
|---|---|
| Asıl Yazarlar: | , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2020
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7959094/ https://ncbi.nlm.nih.gov/pubmed/32926427 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.33176 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|